SMURF1 Provides Targeted Approach to Preventing Cocaine Addiction Relapse
Bats Harbor a Gene Swiped From an Ancient Ebola-Like Virus
New Tool Analyzes Disease And Drug Effects With Unprecedented Accuracy And Consistency
A new protein analysis tool developed at the University at Buffalo could vastly increase the speed and precision with which disease and drug effects are analyzed. The groundbreaking tool, called IonStar, is the first to provide near-perfect accuracy when quantifying and comparing the abundance of proteins in the bodies of people who are healthy and…
UB Spinoff Company Moves One Step Closer to Human Clinical Trials
Scientists from For-Robin Inc., a University at Buffalo biotechnology spinoff, have published new scientific results showing that the company’s cancer-fighting antibody can target, penetrate and kill human tumor cells effectively. The findings, reported in September in the journal Neoplasia, bring the company one step closer to human clinical trials. “This is a very exciting time, because…
Smartphone App Could Improve Antiretroviral Adherence Therapy for HIV Patients
Would people living with HIV be willing to self-report on daily substance use and antiretroviral therapy (ART) adherence using a smartphone app? That was a question researchers from the University at Buffalo set out to answer in a recent study. They were pleased to find that participants not only found the app easy and convenient…
New Smartphone Makes It Easy to Find, Enroll in Clinical Trials
It takes an astounding 17 years, on average, for laboratory breakthroughs to reach patients. A big part of the delay is the time it takes to recruit patients into clinical trials to test new treatments or devices: only 5 to 10 percent of eligible adults enroll in these trials and some studies have found that…